Tuesday, January 12, 2016 12:38:05 PM
Recent QURE News
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/26/2024 01:48:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 11:49:04 AM
- uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS • GlobeNewswire Inc. • 10/15/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 11:35:21 AM
- uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease • GlobeNewswire Inc. • 09/23/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 11:48:04 AM
- uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease • GlobeNewswire Inc. • 08/15/2024 11:05:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/01/2024 12:54:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 11:51:41 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 11:43:22 AM
- uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update • GlobeNewswire Inc. • 08/01/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 11:10:32 AM
- uniQure Announces Closing of Sale of Manufacturing Facility to Genezen • GlobeNewswire Inc. • 07/23/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 11:13:10 AM
- uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease • GlobeNewswire Inc. • 07/09/2024 11:05:00 AM
- uniQure Announces Sale of Commercial Manufacturing Facility to Genezen • GlobeNewswire Inc. • 07/01/2024 11:05:00 AM
- Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA • PR Newswire (US) • 07/01/2024 11:05:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 12:53:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 12:49:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 10:00:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:46:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:40:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:24:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:19:03 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM